MPEG LA is a for profit firm that has historically specialized in getting huge corporations in a room, the patents surrounding a technology all of them need, an

MPEG LA is a for profit firm that has historically specialized in getting huge corporations in a room, the patents surrounding a technology all of them need, and getting them to agree on a standard code to be licensed to everyone: Apple, Cisco, Dolby, Fujitsu, HP, Hitachi, MS, NTT, Panasonic, Samsung, Sony, etc. They have no biomedical or biochemical expertise. They have no hand whatsoever in discovering or understanding any science at all. It now appears as though they would like to try to get another group of mega-companies in a room to cross license their patents on Cas9 variants - there are as many (natural) variants as there are bacteria out there, and there are a combinatorially large number of synthetic variants on top of those. The Berkeley/MIT faceoff you've likely heard about in the news is over a very broad patent on using Cas9 therapeutically, but the space of natural Cas9 variants is actually broader still than even that patent could cover. We as a country need to have a conversation about patents and how the policies that work for computer code may not be the same policies that work for small molecules, which may not be the same processes that work for genetically encoded materials. Each of those technologies are all extreme in terms of the cost of R&D, verifiability, producibility, reproducibilty, and longevity. It is difficult to shoehorn each of these technologies into the same patent framework.